SEARCH

SEARCH BY CITATION

References

  • Almeida L, Soares-da-Silva P. (2007) Eslicarbazepine acetate (BIA 2-093). Neurotherapeutics 4:8896.
  • Almeida L, Bialer M, Soares-da-Silva P. (2009) Eslicarbazepine acetate. In ShorvonS, PeruccaE, EngelJ (Eds) The Treatment of Epilepsy. Blackwell Publishing, Oxford, pp. 485498.
  • Bender RA, Soleymani SV, Brewster AL, Nguyen ST, Beck H, Mathern GW, Baram TZ. (2003) Enhanced expression of a specific hyperpolarization-activated cyclic nucleotide-gated cation channel (HCN) in surviving dentate gyrus granule cells of human and experimental epileptic hippocampus. J Neurosci 23:68266836.
  • Benes J, Parada A, Figueiredo AA, Alves PC, Freitas AP, Learmonth DA, Cunha RA, Garrett J, Soares-da-Silva P. (1999) Anticonvulsant and sodium channel-blocking properties of novel 10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide derivatives. J Med Chem 42:25822587.
  • Ben-Menachem E, Gabbai A, Hufnagel A, Maia J, Almeida L, Soares-da-Silva P. (2008) Efficacy and safety of eslicarbazepine acetate (ESL) as add-on treatment in adults with refractory partial-onset seizures: BIA-2093-302 study. Epilepsia 49(suppl 7):424425.
  • Cramer JA, Perrine K, Devinsky O, Bryant-Comstock L, Meador K, Hermann BP. (1998) Development and cross-cultural translation of a 31-item quality of life questionnaire (QOLIE-31). Epilepsia 39:8188.
  • Elger C, Bialer M, Cramer JA, Maia J, Almeida L, Soares-da-Silva P. (2007) Eslicarbazepine acetate: a double-blind, add-on, placebo-controlled exploratory trial in adult patients with partial-onset seizures. Epilepsia 48:497504.
  • Elger C, Halasz P, Maia J, Almeida L, Soares-da-Silva P. (2009) Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: a randomized, double-blind, placebo-controlled, parallel-group phase III study. Epilepsia 50:454463.
  • Gil-Nagel A, Lopes-Lima J, Almeida L, Maia J, Soares-da-Silva P. (2009) Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures. Acta Neurol Scand 120:281287.
  • Hainzl D, Parada A, Soares-da-Silva P. (2001) Metabolism of two new antiepileptic drugs and their principal metabolites S(+)- and R(-)-10,11-dihydro-10-hydroxy carbamazepine. Epilepsy Res 44:197206.
  • Montgomery SA, Asberg M. (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382389.
  • Potschka H, Pekcec A, Soares-da-Silva P. (2007) Inhibition of kindling progression by eslicarbazepine acetate and licarbazepine. Proceedings of the 27th International Epilepsy Congress, Singapore:Abstract Book.
  • Remy S, Beck H. (2006) Molecular and cellular mechanisms of pharmacoresistance in epilepsy. Brain 129:1835.
  • Remy S, Gabriel S, Urban BW, Dietrich D, Lehmann TN, Elger CE, Heinemann U, Beck H. (2003) A novel mechanism underlying drug resistance in chronic epilepsy. Ann Neurol 53:469479.
  • Shah MM, Anderson AE, Leung V, Lin X, Johnston D. (2004) Seizure-induced plasticity of h channels in entorhinal cortical layer III pyramidal neurons. Neuron 44:495508.
  • Silver JM, Shin C, McNamara JO. (1991) Antiepileptogenic effects of conventional anticonvulsants in the kindling model of epilepsy. Ann Neurol 29:356363.